Processes for the manufacture of rosuvastatin and intermediates

Details for Australian Patent Application No. 2006268024 (hide)

Owner AstraZeneca UK Limited

Inventors Lenger, Steven Robert; Crabb, Jeffrey Norman; Butters, Michael; Cox, David Kenneth; Snape, Evan William; Murray, Paul Michael

Agent Davies Collison Cave

Pub. Number AU-B-2006268024

PCT Pub. Number WO2007/007119

Priority 0514078.5 08.07.05 GB

Filing date 3 July 2006

Wipo publication date 18 January 2007

Acceptance publication date 1 July 2010

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/30 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/36 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/007119 Priority application(s): WO2007/007119

1 July 2010 Application Accepted

  Published as AU-B-2006268024

28 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268034-Diagnostic method for brain damage-related disorders

2006268023-Water swellable polymers as lost circulation control agents material